In line with these findings, elevated levels of irisin were found in individuals with metabolic syndrome and elevated body mass index, thus suggesting the existence of the compensatory secretion of irisin from muscle and AT because of the possible development of “irisin resistance” in subjects with metabolic disease [19]. Here, FNDC5 is linked to metabolic disease.